HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SB 217242

decreases ischemic brain injury; an endothelin A and B receptor antagonist; structure in first source
Also Known As:
3-(2-(2-hydroxyeth-1-yloxy)-4-methoxyphenyl)-1-(3,4-methylenedioxyphenyl)-5-(prop-1-yloxy)indan-2-carboxylic acid; SB-217242; enrasentan
Networked: 13 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cosenzi, Alessandro: 2 articles (01/2003 - 04/2002)
2. Rabasseda, X: 1 article (12/2006)
3. Prous, J R: 1 article (12/2006)
4. Bayes, M: 1 article (12/2006)
5. Prasad, S K: 1 article (06/2006)
6. Smith, G C: 1 article (06/2006)
7. Barlow, M M: 1 article (06/2006)
8. Grothues, F: 1 article (06/2006)
9. Dargie, H J: 1 article (06/2006)
10. Cleland, J G F: 1 article (06/2006)

Related Diseases

1. Neointima
2. Anoxia (Hypoxia)
3. Pulmonary Hypertension (Ayerza Syndrome)
4. Stroke (Strokes)
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. Endothelin Receptors (Endothelin Receptor)
2. Endothelins (Endothelin)
3. Ghrelin
4. Measles-Mumps-Rubella Vaccine (MMR Vaccine)
5. Yellow Fever Vaccine (Vaccine, Yellow Fever)
6. Sirolimus (Rapamycin)
7. Succinic Acid (Succinate)
8. Filgrastim (Neupogen)
9. Interleukin-12 (IL 12)
10. Lisinopril (Prinivil)

Related Therapies and Procedures

1. Stents
2. Parenteral Infusions
3. Oral Administration